To assess the clinical relevance of our findings in the KRAS inducible and reversible lung adenocarcinoma mouse model, we used a publicly available scRNA-seq dataset of KRASG12D-driven and non–KRAS-driven lung cancer (24). This evidence concerns the gene KRAS and lung cancer.